Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.23p
   
  • Change Today:
      0.43p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 8,524,292
  • Market Cap: £11.12m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £33,118
Lisa Baderoon 583,963 £12,993
Tim Franklin 525,000 £11,681

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 44,945,948 £1,000,047
Luca & Associates AG 22,000,000 £489,500
Invesco Ltd 17,872,341 £397,660
Aviva Investors Global 11,285,180 £251,095
Alora Pharmaceuticals LLC 10,909,091 £242,727
M&G Investments 7,600,000 £169,100
Prudential plc 7,600,000 £169,100
Capital Income Builder 4,870,367 £108,366
Dr R Zimmer 4,551,553 £101,272
Odey Asset Management 3,433,319 £76,391
Rhone Trustees (Switzerland) SA 3,386,000 £75,338
Pictet Overseas Trust Corporation Limited 3,287,500 £73,147

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.23p
Change Today 0.43p
% Change 23.78 %
52 Week High 5.90
52 Week Low 1.09
Volume 8,524,292
Shares Issued 499.72m
Market Cap £11.12m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 29-Aug-2025

Time Volume / Share Price
16:29 41,000 @ 2.34p
16:26 65,000 @ 2.24p
16:26 100,000 @ 2.24p
16:22 9,456 @ 2.22p
16:20 13,823 @ 2.24p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page